Follow
Irem Kaymak
Irem Kaymak
Verified email at vai.org
Title
Cited by
Cited by
Year
Immunometabolic interplay in the tumor microenvironment
I Kaymak, KS Williams, JR Cantor, RG Jones
Cancer cell 39 (1), 28-37, 2021
2182021
Regulation of metabolic activity by p53
J Flöter, I Kaymak, A Schulze
Metabolites 7 (2), 21, 2017
982017
Mevalonate pathway provides ubiquinone to maintain pyrimidine synthesis and survival in p53-deficient cancer cells exposed to metabolic stress
I Kaymak, CR Maier, W Schmitz, AD Campbell, B Dankworth, CP Ade, ...
Cancer Research 80 (2), 189-203, 2020
692020
6-Phosphofructo-2-kinase/fructose-2, 6-biphosphatase 4 is essential for p53-null cancer cells
S Ros, J Flöter, I Kaymak, C Da Costa, A Houddane, S Dubuis, B Griffiths, ...
Oncogene 36 (23), 3287-3299, 2017
692017
Carbon source availability drives nutrient utilization in CD8+ T cells
I Kaymak, KM Luda, LR Duimstra, EH Ma, J Longo, MS Dahabieh, ...
Cell metabolism 34 (9), 1298-1311. e6, 2022
572022
Immunometabolism in the tumor microenvironment
DG Roy, I Kaymak, KS Williams, EH Ma, RG Jones
Annual Review of Cancer Biology 5, 137-159, 2021
322021
Repression of LKB1 by miR-17∼ 92 sensitizes MYC-dependent lymphoma to biguanide treatment
S Izreig, A Gariepy, I Kaymak, HR Bridges, AO Donayo, G Bridon, ...
Cell Reports Medicine 1 (2), 2020
252020
T helper 2 cells control monocyte to tissue-resident macrophage differentiation during nematode infection of the pleural cavity
CM Finlay, JE Parkinson, L Zhang, BHK Chan, J Ajendra, A Chenery, ...
Immunity 56 (5), 1064-1081. e10, 2023
182023
Ketolysis drives CD8+ T cell effector function through effects on histone acetylation
KM Luda, J Longo, SM Kitchen-Goosen, LR Duimstra, EH Ma, ...
Immunity 56 (9), 2021-2035. e8, 2023
162023
Amino acid availability acts as a metabolic rheostat to determine the magnitude of ILC2 responses
SH Hodge, MZ Krauss, I Kaymak, JI King, AJM Howden, G Panic, ...
Journal of Experimental Medicine 220 (3), e20221073, 2022
102022
Protein phosphatase 4 controls circadian clock dynamics by modulating CLOCK/BMAL1 activity
S Klemz, T Wallach, S Korge, M Rosing, R Klemz, B Maier, NC Fiorenza, ...
Genes & Development 35 (15-16), 1161-1174, 2021
102021
Ketolysis is a metabolic driver of CD8+ T cell effector function through histone acetylation
KM Luda, SM Kitchen-Goosen, EH Ma, MLJ Watson, LR Duimstra, ...
bioRxiv, 2022.08. 26.505402, 2022
22022
13C metabolite tracing reveals glutamine and acetate as critical in vivo fuels for CD8+ T cells
EH Ma, MS Dahabieh, LM DeCamp, I Kaymak, SM Kitchen-Goosen, ...
bioRxiv, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–13